• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于日本和歌山县通过全面普查连续 13 年的队列研究,确定川崎病相关冠状动脉病变的流行病学特征和预后因素。

Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan.

机构信息

Department of Public Health, School of Medicine, Wakayama Medical University.

出版信息

J Epidemiol. 2014;24(5):427-34. doi: 10.2188/jea.je20140018. Epub 2014 Jul 5.

DOI:10.2188/jea.je20140018
PMID:24998951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4150015/
Abstract

BACKGROUND

To clarify the contribution of patient age to the development of coronary artery lesions (CALs) associated with Kawasaki disease (KD), epidemiologic features and prognostic factors were investigated using hospital-based complete enumeration surveys in a specific area.

METHODS

Consecutive KD cases identified between October 1999 and September 2012 in Wakayama Prefecture, Japan, were analyzed. The primary outcome measure was the presence/absence of CALs (giant aneurysm, mid- or small-sized aneurysm, and dilatation) on echocardiography 1 month after disease onset. Demographics and medical treatment factors were compared between the patients with and without CALs. Odds ratios (ORs) and 95% confidence intervals (CIs) of explanatory variables (age, gender, and factors related to high-dose intravenous immunoglobulin treatment) for the development of CALs were determined.

RESULTS

The median age of the 1415 patients (796 males, 619 females) was 25 months after excluding 2 children of foreign residents; 2.2% of the patients had a past history of KD, and 1.8% showed incomplete presentation. CALs were observed in 3.3% (4.0% of males, 2.3% of females; P = 0.080). The ORs of CALs among patients <11 months old (3.0, 95% CI 1.4-6.6) and those >48 months old (3.1, 95% CI 1.5-6.6) were significantly higher than values in 11- to 48-month-olds.

CONCLUSIONS

The effect of patient age on the development of CALs was found to be U-shaped, with the bottom at ages 11 to 48 months. This finding was based on a 13-year cohort of consecutive KD cases in a specific area with little selection bias and is consistent with previously reported results.

摘要

背景

为了阐明患者年龄对川崎病(KD)相关冠状动脉病变(CALs)发展的影响,本研究采用特定区域基于医院的全面普查方法,对流行病学特征和预后因素进行了调查。

方法

分析了日本和歌山县 1999 年 10 月至 2012 年 9 月期间确诊的连续 KD 病例。主要观察指标为发病后 1 个月时超声心动图上是否存在(巨大动脉瘤、中或小动脉瘤和扩张)CALs。比较了有和无 CALs 患者的人口统计学和医学治疗因素。确定了对 CALs 发生有解释意义的变量(年龄、性别和与大剂量静脉注射免疫球蛋白治疗相关的因素)的优势比(OR)和 95%置信区间(CI)。

结果

排除 2 例外国居民儿童后,1415 例患者(796 例男性,619 例女性)的中位年龄为 25 个月;2.2%的患者有 KD 既往史,1.8%表现为不完全型。3.3%(男性 4.0%,女性 2.3%;P=0.080)的患者出现 CALs。<11 个月(3.0,95%CI 1.4-6.6)和>48 个月(3.1,95%CI 1.5-6.6)的患者发生 CALs 的 OR 明显高于 11-48 个月龄患者。

结论

患者年龄对 CALs 发展的影响呈 U 型,底部在 11-48 个月龄。该发现基于特定区域连续 KD 病例的 13 年队列,几乎没有选择偏倚,与以往报道的结果一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7980/4150015/062530671385/je-24-427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7980/4150015/062530671385/je-24-427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7980/4150015/062530671385/je-24-427-g001.jpg

相似文献

1
Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan.基于日本和歌山县通过全面普查连续 13 年的队列研究,确定川崎病相关冠状动脉病变的流行病学特征和预后因素。
J Epidemiol. 2014;24(5):427-34. doi: 10.2188/jea.je20140018. Epub 2014 Jul 5.
2
Seasonal Variation in Epidemiology of Kawasaki Disease-Related Coronary Artery Abnormalities in Japan, 1999-2017.日本 1999-2017 年川崎病相关冠状动脉异常的流行病学的季节性变化。
J Epidemiol. 2021 Feb 5;31(2):132-138. doi: 10.2188/jea.JE20190189. Epub 2020 Feb 22.
3
Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.川崎病患者入院时伴有冠状动脉异常的结局。
Am Heart J. 2020 Jul;225:120-128. doi: 10.1016/j.ahj.2020.04.019. Epub 2020 May 3.
4
Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.日本川崎病患儿的年龄、性别、静脉注射免疫球蛋白无反应和冠状动脉异常分析。
JAMA Netw Open. 2022 Jun 1;5(6):e2216642. doi: 10.1001/jamanetworkopen.2022.16642.
5
Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.10年间完全性和不完全性川崎病患儿冠状动脉异常的流行病学及危险因素
Pediatr Cardiol. 2013 Aug;34(6):1476-81. doi: 10.1007/s00246-013-0673-9. Epub 2013 Mar 6.
6
Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.川崎病可能出现面神经麻痹,表明冠状动脉病变。
Clin Rheumatol. 2021 Oct;40(10):4191-4197. doi: 10.1007/s10067-021-05791-8. Epub 2021 May 31.
7
Kawasaki Disease With Coronary Artery Lesions Detected at Initial Echocardiography.川崎病伴冠状动脉病变的初始超声心动图表现
J Am Heart Assoc. 2021 Apr 6;10(7):e019853. doi: 10.1161/JAHA.120.019853. Epub 2021 Mar 31.
8
Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan.不完全川崎病的冠状动脉病变:日本全国性调查。
Eur J Pediatr. 2012 Apr;171(4):651-6. doi: 10.1007/s00431-011-1630-3. Epub 2011 Dec 10.
9
Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.延迟静脉注射免疫球蛋白治疗增加了不同状态川崎病患儿冠状动脉病变的风险。
Postgrad Med. 2018 May;130(4):442-447. doi: 10.1080/00325481.2018.1468712. Epub 2018 May 10.
10
Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.川崎病所致急性心脏病变亚型的危险因素差异。
Pediatr Cardiol. 2017 Feb;38(2):375-380. doi: 10.1007/s00246-016-1525-1. Epub 2016 Nov 23.

引用本文的文献

1
Comprehensive assessment of patients with Kawasaki disease without coronary artery aneurysm.对无冠状动脉瘤的川崎病患者的综合评估
Quant Imaging Med Surg. 2025 Sep 1;15(9):8348-8358. doi: 10.21037/qims-2024-2772. Epub 2025 Aug 13.
2
MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring.川崎病相关 microRNAs:诊断、治疗和监测的新进展。
Front Immunol. 2022 Oct 24;13:1016575. doi: 10.3389/fimmu.2022.1016575. eCollection 2022.
3
An Angiotensinogen Gene Polymorphism (rs5050) Is Associated with the Risk of Coronary Artery Aneurysm in Southern Chinese Children with Kawasaki Disease.

本文引用的文献

1
Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011.韩国川崎病的流行病学特征:2009 - 2011年全国性调查数据
Pediatr Infect Dis J. 2014 Jan;33(1):24-7. doi: 10.1097/INF.0000000000000010.
2
Epidemiology of Kawasaki disease in infants 3 months of age and younger.3个月及以下婴儿川崎病的流行病学
Korean J Pediatr. 2012 Jun;55(6):202-5. doi: 10.3345/kjp.2012.55.6.202. Epub 2012 Jun 21.
3
Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.川崎病在疑似心肌缺血的年轻成年人中的患病率。
血管紧张素原基因多态性(rs5050)与南方汉族儿童川崎病冠状动脉瘤的风险相关。
Dis Markers. 2019 Jan 3;2019:2849695. doi: 10.1155/2019/2849695. eCollection 2019.
4
High antistreptolysin O titer is associated with coronary artery lesions in patients with Kawasaki disease.抗链球菌溶血素O滴度升高与川崎病患者的冠状动脉病变有关。
Korean J Pediatr. 2019 Jun;62(6):235-239. doi: 10.3345/kjp.2018.06989. Epub 2018 Nov 7.
5
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.川崎病:意大利儿科学会指南,第一部分-定义、流行病学、病因发病机制、急性期临床表现和治疗。
Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3.
6
Treatment Options for Resistant Kawasaki Disease.难治性川崎病的治疗选择
Paediatr Drugs. 2018 Feb;20(1):59-80. doi: 10.1007/s40272-017-0269-6.
7
Atypical desquamation in a 2.5-year-old boy with Kawasaki disease: A case report.一名2.5岁川崎病男孩的非典型脱屑:病例报告
Electron Physician. 2017 Feb 25;9(2):3764-3767. doi: 10.19082/3764. eCollection 2017 Feb.
8
Pathogenetic determinants in Kawasaki disease: the haematological point of view.川崎病的发病机制决定因素:血液学视角
J Cell Mol Med. 2017 Apr;21(4):632-639. doi: 10.1111/jcmm.12992. Epub 2017 Jan 7.
9
Receptor for advanced glycation end products involved in circulating endothelial cells release from human coronary endothelial cells induced by C-reactive protein.晚期糖基化终末产物受体参与C反应蛋白诱导的人冠状动脉内皮细胞释放循环内皮细胞。
Iran J Basic Med Sci. 2015 Jun;18(6):610-5.
10
A second look at surgical repair of a distal coronary artery fistula: Stems from trunk.再次审视冠状动脉远端瘘的手术修复:起源于主干。
Ann Pediatr Cardiol. 2015 May-Aug;8(2):172-4. doi: 10.4103/0974-2069.157043.
Circulation. 2012 May 22;125(20):2447-53. doi: 10.1161/CIRCULATIONAHA.111.082107. Epub 2012 May 17.
4
Clinical manifestations vary with different age spectrums in infants with Kawasaki disease.川崎病婴儿的临床表现因年龄范围不同而有所差异。
ScientificWorldJournal. 2012;2012:210382. doi: 10.1100/2012/210382. Epub 2012 Feb 15.
5
Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.日本川崎病的流行病学特征:2009-2010 年全国调查结果。
J Epidemiol. 2012;22(3):216-21. doi: 10.2188/jea.je20110126. Epub 2012 Mar 10.
6
Epidemiology of Kawasaki disease in Asia, Europe, and the United States.川崎病在亚洲、欧洲和美国的流行病学。
J Epidemiol. 2012;22(2):79-85. doi: 10.2188/jea.je20110131. Epub 2012 Feb 4.
7
Late intravenous immunoglobulin treatment in patients with Kawasaki disease.川崎病患者的晚期静脉注射免疫球蛋白治疗。
Pediatrics. 2012 Feb;129(2):e291-7. doi: 10.1542/peds.2011-1704. Epub 2012 Jan 16.
8
Standard method for ultrasound imaging of coronary artery in children.儿童冠状动脉超声成像的标准方法。
Pediatr Int. 2010 Dec;52(6):876-82. doi: 10.1111/j.1442-200X.2010.03252.x.
9
Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii.夏威夷儿童川崎病发病率的种族/民族差异。
Hawaii Med J. 2010 Aug;69(8):194-7.
10
Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.川崎病所致巨大冠状动脉瘤的病例对照研究:第19次全国性调查
Pediatr Int. 2010 Oct;52(5):790-4. doi: 10.1111/j.1442-200X.2010.03161.x.